Literature DB >> 30542090

A diet enriched with curcumin promotes resilience to chronic social defeat stress.

Antonio V Aubry1,2, Hameda Khandaker1,3, Rebecca Ravenelle1,4, Itamar S Grunfeld1,3, Valentina Bonnefil5, Kenny L Chan2, Flurin Cathomas2, Jia Liu5, Glenn E Schafe1,3, Nesha S Burghardt6,7.   

Abstract

Chronic exposure to stress is a well-known risk factor for the development of mood and anxiety disorders. Promoting resilience to stress may prevent the development of these disorders, but resilience-enhancing compounds are not yet clinically available. One compound that has shown promise in the clinical setting is curcumin, a polyphenol compound found in the rhizome of the turmeric plant (Curcuma longa) with known anti-inflammatory and antidepressant properties. Here, we tested the efficacy of 1.5% dietary curcumin at promoting resilience to chronic social defeat stress (CSDS) in 129/SvEv mice, a strain that we show is highly susceptible to this type of stress. We found that administration of curcumin during CSDS produced a 4.5-fold increase in stress resilience, as measured by the social interaction test. Although the overall effects of curcumin were striking, we identified two distinct responses to curcumin. While 64% of defeated mice on curcumin were resilient (responders), the remaining 36% of mice were susceptible to the effects of stress (non-responders). Interestingly, responders released less corticosterone following acute restraint stress and had lower levels of peripheral IL-6 than nonresponders, implicating a role for the NF-κB pathway in treatment response. Importantly, curcumin also prevented anxiety-like behavior in both responders and non-responders in the elevated-plus maze and open field test. Collectively, our findings provide the first preclinical evidence that curcumin promotes resilience to CSDS and suggest that curcumin may prevent the emergence of a range of anxiety-like symptoms when given to individuals during exposure to chronic social stress.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30542090      PMCID: PMC6372632          DOI: 10.1038/s41386-018-0295-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  Causal relationship between stressful life events and the onset of major depression.

Authors:  K S Kendler; L M Karkowski; C A Prescott
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

2.  TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.

Authors:  Thomas Y Ma; Gary K Iwamoto; Neil T Hoa; Vimesh Akotia; Ali Pedram; Michel A Boivin; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03       Impact factor: 4.052

3.  Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.

Authors:  Vaishnav Krishnan; Ming-Hu Han; Danielle L Graham; Olivier Berton; William Renthal; Scott J Russo; Quincey Laplant; Ami Graham; Michael Lutter; Diane C Lagace; Subroto Ghose; Robin Reister; Paul Tannous; Thomas A Green; Rachael L Neve; Sumana Chakravarty; Arvind Kumar; Amelia J Eisch; David W Self; Francis S Lee; Carol A Tamminga; Donald C Cooper; Howard K Gershenfeld; Eric J Nestler
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

4.  Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.

Authors:  Ying Xu; Baoshan Ku; Lu Tie; Haiyan Yao; Wengao Jiang; Xing Ma; Xuejun Li
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

5.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity.

Authors:  C Jobin; C A Bradham; M P Russo; B Juma; A S Narula; D A Brenner; R B Sartor
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

6.  Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

Authors:  Hiroyuki Hanai; Takayuki Iida; Ken Takeuchi; Fumitoshi Watanabe; Yasuhiko Maruyama; Akira Andoh; Tomoyuki Tsujikawa; Yosihihide Fujiyama; Keiichi Mitsuyama; Michio Sata; Masami Yamada; Yasushi Iwaoka; Kazunari Kanke; Hideyuki Hiraishi; Kazuhisa Hirayama; Hajime Arai; Shigehito Yoshii; Masato Uchijima; Toshi Nagata; Yukio Koide
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11-13       Impact factor: 11.382

Review 7.  Chemopreventive and therapeutic effects of curcumin.

Authors:  Annelyse Duvoix; Romain Blasius; Sylvie Delhalle; Michaël Schnekenburger; Franck Morceau; Estelle Henry; Mario Dicato; Marc Diederich
Journal:  Cancer Lett       Date:  2004-11-11       Impact factor: 8.679

Review 8.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice.

Authors:  A Holmes; C C Wrenn; A P Harris; K E Thayer; J N Crawley
Journal:  Genes Brain Behav       Date:  2002-01       Impact factor: 3.449

9.  Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.

Authors:  Olivier Berton; Colleen A McClung; Ralph J Dileone; Vaishnav Krishnan; William Renthal; Scott J Russo; Danielle Graham; Nadia M Tsankova; Carlos A Bolanos; Maribel Rios; Lisa M Monteggia; David W Self; Eric J Nestler
Journal:  Science       Date:  2006-02-10       Impact factor: 47.728

10.  Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice.

Authors:  Valeria Carola; Francesca D'Olimpio; Emiliano Brunamonti; Franco Mangia; Paolo Renzi
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

View more
  7 in total

1.  Formulated Curcumin Prevents Paclitaxel-Induced Peripheral Neuropathy through Reduction in Neuroinflammation by Modulation of α7 Nicotinic Acetylcholine Receptors.

Authors:  Martial Caillaud; Danielle Thompson; Wisam Toma; Alyssa White; Jared Mann; Jane L Roberts; John W Bigbee; David A Gewirtz; M Imad Damaj
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

Review 2.  Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.

Authors:  Mohammad Amin Khodadadegan; Shakiba Azami; Paul C Guest; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Social status and modern-type depression: A review.

Authors:  Takashi Komori; Manabu Makinodan; Toshifumi Kishimoto
Journal:  Brain Behav       Date:  2019-11-19       Impact factor: 2.708

Review 4.  Interplay of Nutrition and Psychoneuroendocrineimmune Modulation: Relevance for COVID-19 in BRICS Nations.

Authors:  Arundhati Mehta; Yashwant Kumar Ratre; Krishna Sharma; Vivek Kumar Soni; Atul Kumar Tiwari; Rajat Pratap Singh; Mrigendra Kumar Dwivedi; Vikas Chandra; Santosh Kumar Prajapati; Dhananjay Shukla; Naveen Kumar Vishvakarma
Journal:  Front Microbiol       Date:  2021-12-17       Impact factor: 5.640

Review 5.  Potential Role of Curcumin for the Treatment of Major Depressive Disorder.

Authors:  Adrian L Lopresti
Journal:  CNS Drugs       Date:  2022-02-07       Impact factor: 5.749

Review 6.  Nutritional interventions for promoting stress resilience: Recent progress using psychosocial stress models of rodents.

Authors:  Atsushi Toyoda
Journal:  Anim Sci J       Date:  2020-01       Impact factor: 1.749

7.  Curcumin inhibits adverse psychological stress-induced proliferation and invasion of glioma cells via down-regulating the ERK/MAPK pathway.

Authors:  Ping Wang; Xinwei Hao; Xiaohan Li; Yizhi Yan; Wenxiu Tian; Lin Xiao; Zhenming Wang; Junhong Dong
Journal:  J Cell Mol Med       Date:  2021-06-25       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.